Environmental Health Sciences Research Center

University of Iowa College of Public Health

  • Facebook
  • Twitter
  • Home
  • About
    • Overview
    • People
    • Membership Information
    • News
    • EHS Core Centers Meeting 2019
  • Resources & Opportunities
    • Pilot Grant Program
    • Career Enhancement Program
    • Seminars
    • NIEHS Funding Opportunities
    • BioBank Information
    • Disaster Response Protocol
  • Center Research
    • Publications
    • Research Themes
    • Core Facilities
  • Community Engagement
    • About the Community Engagement Core
    • Activities & Services
    • Resources & Information
    • Science Café
  • Contact
  • Response to COVID-19
You are here: Home / Team Showcase / Jonathan A. Doorn, PhD

Jonathan A. Doorn, PhD

October 17, 2018 By

Center affiliation: Co-Leader, Systemic and Redox Toxicology Thematic Area

Dr. Doorns’ work involves examining the role of reactive intermediates in toxicity and disease. Specifically, his mechanistic, hypothesis-driven research focuses on the potential role of protein modification by a reactive metabolite of dopamine metabolism in neurotoxicity and neurodegenerative disease, i.e. Parkinson’s disease. Dopamine (DA) is an important neurotransmitter that is metabolized by monoamine oxidase to 3,4-dihydroxyphenylacetaldehyde (DOPAL), an intermediate shown to be reactive toward proteins and toxic to dopaminergic cells. Specifically, the following areas are being investigated. (1) Characterize the chemistry of DOPAL, with emphasis on determining DOPAL reactivity toward proteins and identifying novel ways to synthesize the DA-derived aldehyde. (2) Elucidate mechanisms for generation of DOPAL at aberrant concentrations, involving exposure to drugs, oxidative stress and environmental agents. (3) Identify proteins modified by DOPAL. The Doorn lab is developing a proteomics-based approach to isolate and identify proteins with DOPAL adducts. (4) Determine the functional consequence of protein modification by DOPAL. Several potential targets are being studied, including the proteasome and proteins involved in DA synthesis and trafficking. In summary, the Dr. Doorn is studying the biological chemistry of DOPAL, as aberrant levels of the DA-derived aldehyde may represent a chemical trigger for neurodegeneration (e.g. PD). This work is highly significant as outcomes of the research may yield novel targets for therapeutic intervention, and future work will evaluate the potential of aldehyde-scavenging drugs to attenuate DOPAL- mediated toxicity and neurodegeneration.

Selected Publications:

  • Complete List of Published Work in My Bibliography:

Sign up for Email Updates

Stay up-to-date with the latest from the EHSRC.
  • This field is for validation purposes and should be left unchanged.

EHSRC Logo

Environmental Health Sciences Research Center | S300 CPHB | Iowa City, IA 52242-5000 | (319) 335-4756


The EHSRC is funded by NIH P30 ES005605

National Institute of Environmental Health Sciences logo


© The College of Public Health - The University of Iowa. All rights reserved. | Accessibility Statement